Key result
Low-dose ethinyl estradiol/desogestrel increased endothelium-dependent vasodilation during the active phase vs no hormone phase, an effect not seen with very low-dose pills.
Why the study?
Does the ratio of ethinyl estradiol to desogestrel in oral contraceptives affect endothelial function in young women?
Observational (n=22)
Does the ratio of ethinyl estradiol to desogestrel in oral contraceptives affect endothelial function in young women?
The ratio of ethinyl estradiol to progestin in oral contraceptives significantly impacts endothelial function, with desogestrel potentially antagonizing the vasodilatory effects of ethinyl estradiol at very low doses.
Answers are grounded in this paper and cite their sources.
Low-dose ethinyl estradiol/desogestrel may enhance endothelial function; hypothesis-generating for dose-ratio effects on vascular outcomes.
Endothelial function fluctuates across the cycle in women taking ethinyl estradiol (EE) and levonorgestrel oral contraceptive pills (OCPs). The type of progestin and ratio of EE to progestin used in OCPs may determine how they affect the arterial vasculature. PURPOSE: Therefore, the purpose of this study was to gain a better understanding as to how the progestin desogestrel affects endothelial function in young women and to determine if the ratio of EE to desogestrel used in OCPs impacts the pattern of endothelial function across an oral contraceptive cycle. METHODS: Endothelial function was measured across an oral contraceptive cycle in 11 very low dose (VLD) and 11 low dose (LD) combination EE and desogestrel (DSG) OCP users during two hormone phases; active phase (VLD=20μg EE/150μg DSG; LD=30μg EE/150μg DSG) and no hormone phase. Endothelial function was also measured during an EE hormone phase (10μg EE) in group VLD. Wall tracking of high resolution ultrasound images of the brachial artery were used during flow mediated vasodilation and nitroglycerin administration to test endothelium-dependent and endothelium-independent vasodilation, respectively. RESULTS: Endothelium-dependent vasodilation was greater during the active phase compared to the no hormone phase in group LD (9.02 ± 0.72% vs. 7.33 ± 0.84%; p=0.029). This phase difference was not observed in group VLD (5.86 ± 0.63% vs. 6.56 ± 0.70%; p=0.108). However, endothelium-dependent vasodilation increased in group VLD during the EE phase, when EE was given independently of DSG, compared to the active and no hormone phases (8.92 ± 0.47% vs. 5.86 ± 0.63%, and 6.56 ± 0.70%; p<0.001). No differences were observed in baseline brachial artery diameters or shear rates between groups or hormone phases. CONCLUSIONS: These data suggest DSG may antagonize the vasodilatory activity of EE. Additionally, these data bring to light the importance of the EE to progestin ratio in determining how specific OCs affect the arterial vasculature in young women.
No takes yet. Share an insight, caveat, or question.
Meendering et al. (2008) conducted an observational in Oral contraceptive use (n=22). Ethinyl estradiol and desogestrel oral contraceptive pills vs. No hormone phase was evaluated on Endothelium-dependent vasodilation (p=0.029). Low-dose ethinyl estradiol/desogestrel increased endothelium-dependent vasodilation during the active phase vs no hormone phase, an effect not seen with very low-dose pills.
Synapse has enriched 10 related papers. Consider them for comparative context: